Orforglipron
RESTRAIN-SUI
Eli Lilly · Phase 3 · Recruiting · Enrollment 1000
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Orforglipron (GZS1) | Urinary Incontinence,Stress | n/r | 58 | n/r | n/r |
| Placebo (GZS1) | Urinary Incontinence,Stress | n/r | 58 | n/r | n/r |
| Orforglipron (GZS2) | Urinary Incontinence,Stress | n/r | 58 | n/r | n/r |
| Placebo (GZS2) | Urinary Incontinence,Stress | n/r | 58 | n/r | n/r |